Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  • Sasha Bernatsky
  • Rosalind Ramsey-Goldman
  • Murray B Urowitz
  • John G Hanly
  • Caroline Gordon
  • Michelle A Petri
  • Ellen M Ginzler
  • Daniel J Wallace
  • Sang-Cheol Bae
  • Juanita Romero-Diaz
  • Mary Anne Dooley
  • Christine A Peschken
  • David A Isenberg
  • Anisur Rahman
  • Susan Manzi
  • Søren Jacobsen
  • S Sam Lim
  • Ronald van Vollenhoven
  • Ola Nived
  • Diane L Kamen
  • Cynthia Aranow
  • Guillermo Ruiz-Irastorza
  • Jorge Sánchez-Guerrero
  • Dafna D Gladman
  • Paul R Fortin
  • Graciela S Alarcón
  • Joan T Merrill
  • Kenneth C Kalunian
  • Manuel Ramos-Casals
  • Kristjan Steinsson
  • Asad Zoma
  • Anca Askanase
  • Munther A Khamashta
  • Ian Bruce
  • Murat Inanc
  • Ann E Clarke
Vis graf over relationer

OBJECTIVE: To assess cancer risk factors in incident systemic lupus erythematosus (SLE).

METHODS: Clinical variables and cancer outcomes were assessed annually among incident SLE patients. Multivariate hazard regression models (overall risk and most common cancers) included demographic characteristics and time-dependent medications (corticosteroids, antimalarial drugs, immunosuppressants), smoking, and the adjusted mean Systemic Lupus Erythematosus Disease Activity Index 2000 score.

RESULTS: Among 1,668 patients (average 9 years follow-up), 65 cancers occurred: 15 breast, 10 nonmelanoma skin, 7 lung, 6 hematologic, 6 prostate, 5 melanoma, 3 cervical, 3 renal, 2 each gastric, head and neck, and thyroid, and 1 each rectal, sarcoma, thymoma, and uterine cancers. Half of the cancers (including all lung cancers) occurred in past/current smokers, versus one-third of patients without cancer. Multivariate analyses indicated that overall cancer risk was related primarily to male sex and older age at SLE diagnosis. In addition, smoking was associated with lung cancer. For breast cancer risk, age was positively associated and antimalarial drugs were negatively associated. Antimalarial drugs and higher disease activity were also negatively associated with nonmelanoma skin cancer risk, whereas age and cyclophosphamide were positively associated. Disease activity was associated positively with hematologic and negatively with nonmelanoma skin cancer risk.

CONCLUSION: Smoking is a key modifiable risk factor, especially for lung cancer, in SLE. Immunosuppressive medications were not clearly associated with higher risk except for cyclophosphamide and nonmelanoma skin cancer. Antimalarials were negatively associated with breast cancer and nonmelanoma skin cancer risk. SLE activity was associated positively with hematologic cancer and negatively with nonmelanoma skin cancer. Since the absolute number of cancers was small, additional follow-up will help consolidate these findings.

OriginalsprogEngelsk
TidsskriftArthritis Care & Research
Vol/bind73
Udgave nummer12
Sider (fra-til)1789-1795
Antal sider7
ISSN2151-464X
DOI
StatusUdgivet - dec. 2021

Bibliografisk note

© 2020, American College of Rheumatology.

ID: 74078454